206 related articles for article (PubMed ID: 28040834)
1. Aldehyde dehydrogenase activity plays no functional role in stem cell-like properties in anaplastic thyroid cancer cell lines.
Shimamura M; Kurashige T; Mitsutake N; Nagayama Y
Endocrine; 2017 Mar; 55(3):934-943. PubMed ID: 28040834
[TBL] [Abstract][Full Text] [Related]
2. The sonic hedgehog signaling pathway maintains the cancer stem cell self-renewal of anaplastic thyroid cancer by inducing snail expression.
Heiden KB; Williamson AJ; Doscas ME; Ye J; Wang Y; Liu D; Xing M; Prinz RA; Xu X
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2178-87. PubMed ID: 25078145
[TBL] [Abstract][Full Text] [Related]
3. Disulfiram/copper targets stem cell-like ALDH
Jin N; Zhu X; Cheng F; Zhang L
J Cell Biochem; 2018 Aug; 119(8):6882-6893. PubMed ID: 29665144
[TBL] [Abstract][Full Text] [Related]
4. Analysis of multiple markers for cancer stem-like cells in human thyroid carcinoma cell lines.
Shimamura M; Nagayama Y; Matsuse M; Yamashita S; Mitsutake N
Endocr J; 2014; 61(5):481-90. PubMed ID: 24531915
[TBL] [Abstract][Full Text] [Related]
5. The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance.
Moreb JS; Ucar D; Han S; Amory JK; Goldstein AS; Ostmark B; Chang LJ
Chem Biol Interact; 2012 Jan; 195(1):52-60. PubMed ID: 22079344
[TBL] [Abstract][Full Text] [Related]
6. Intracellular redox status controls spherogenicity, an in vitro cancer stem cell marker, in thyroid cancer cell lines.
Shimamura M; Yamamoto K; Kurashige T; Nagayama Y
Exp Cell Res; 2018 Sep; 370(2):699-707. PubMed ID: 30053445
[TBL] [Abstract][Full Text] [Related]
7. JAK/STAT3 and NF-κB Signaling Pathways Regulate Cancer Stem-Cell Properties in Anaplastic Thyroid Cancer Cells.
Shiraiwa K; Matsuse M; Nakazawa Y; Ogi T; Suzuki K; Saenko V; Xu S; Umezawa K; Yamashita S; Tsukamoto K; Mitsutake N
Thyroid; 2019 May; 29(5):674-682. PubMed ID: 30784360
[No Abstract] [Full Text] [Related]
8. Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44⁺ human breast cancer cells.
Croker AK; Allan AL
Breast Cancer Res Treat; 2012 May; 133(1):75-87. PubMed ID: 21818590
[TBL] [Abstract][Full Text] [Related]
9. Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma.
Flahaut M; Jauquier N; Chevalier N; Nardou K; Balmas Bourloud K; Joseph JM; Barras D; Widmann C; Gross N; Renella R; Mühlethaler-Mottet A
BMC Cancer; 2016 Oct; 16(1):781. PubMed ID: 27724856
[TBL] [Abstract][Full Text] [Related]
10. N,N-diethylaminobenzaldehyde (DEAB) as a substrate and mechanism-based inhibitor for human ALDH isoenzymes.
Morgan CA; Parajuli B; Buchman CD; Dria K; Hurley TD
Chem Biol Interact; 2015 Jun; 234():18-28. PubMed ID: 25512087
[TBL] [Abstract][Full Text] [Related]
11. Citral reduces breast tumor growth by inhibiting the cancer stem cell marker ALDH1A3.
Thomas ML; de Antueno R; Coyle KM; Sultan M; Cruickshank BM; Giacomantonio MA; Giacomantonio CA; Duncan R; Marcato P
Mol Oncol; 2016 Nov; 10(9):1485-1496. PubMed ID: 27592281
[TBL] [Abstract][Full Text] [Related]
12. ALDH1A inhibition sensitizes colon cancer cells to chemotherapy.
Kozovska Z; Patsalias A; Bajzik V; Durinikova E; Demkova L; Jargasova S; Smolkova B; Plava J; Kucerova L; Matuskova M
BMC Cancer; 2018 Jun; 18(1):656. PubMed ID: 29902974
[TBL] [Abstract][Full Text] [Related]
13. Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway.
Shao C; Sullivan JP; Girard L; Augustyn A; Yenerall P; Rodriguez-Canales J; Liu H; Behrens C; Shay JW; Wistuba II; Minna JD
Clin Cancer Res; 2014 Aug; 20(15):4154-66. PubMed ID: 24907115
[TBL] [Abstract][Full Text] [Related]
14. Aldehyde dehydrogenase 3A1 is robustly upregulated in gastric cancer stem-like cells and associated with tumorigenesis.
Wu D; Mou YP; Chen K; Cai JQ; Zhou YC; Pan Y; Xu XW; Zhou W; Gao JQ; Chen DW; Zhang RC
Int J Oncol; 2016 Aug; 49(2):611-22. PubMed ID: 27279633
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells.
Liu P; Brown S; Goktug T; Channathodiyil P; Kannappan V; Hugnot JP; Guichet PO; Bian X; Armesilla AL; Darling JL; Wang W
Br J Cancer; 2012 Oct; 107(9):1488-97. PubMed ID: 23033007
[TBL] [Abstract][Full Text] [Related]
16. High aldehyde dehydrogenase activity enhances stem cell features in breast cancer cells by activating hypoxia-inducible factor-2α.
Kim RJ; Park JR; Roh KJ; Choi AR; Kim SR; Kim PH; Yu JH; Lee JW; Ahn SH; Gong G; Hwang JW; Kang KS; Kong G; Sheen YY; Nam JS
Cancer Lett; 2013 Jun; 333(1):18-31. PubMed ID: 23174107
[TBL] [Abstract][Full Text] [Related]
17. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.
Marcato P; Dean CA; Pan D; Araslanova R; Gillis M; Joshi M; Helyer L; Pan L; Leidal A; Gujar S; Giacomantonio CA; Lee PW
Stem Cells; 2011 Jan; 29(1):32-45. PubMed ID: 21280157
[TBL] [Abstract][Full Text] [Related]
18. Distinct expression patterns and roles of aldehyde dehydrogenases in normal oral mucosa keratinocytes: differential inhibitory effects of a pharmacological inhibitor and RNAi-mediated knockdown on cellular phenotype and epithelial morphology.
Kato H; Izumi K; Saito T; Ohnuki H; Terada M; Kawano Y; Nozawa-Inoue K; Saito C; Maeda T
Histochem Cell Biol; 2013 Jun; 139(6):847-62. PubMed ID: 23250514
[TBL] [Abstract][Full Text] [Related]
19. Generation of Novel Thyroid Cancer Stem-Like Cell Clones: Effects of Resveratrol and Valproic Acid.
Hardin H; Yu XM; Harrison AD; Larrain C; Zhang R; Chen J; Chen H; Lloyd RV
Am J Pathol; 2016 Jun; 186(6):1662-73. PubMed ID: 27060227
[TBL] [Abstract][Full Text] [Related]
20. Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy.
Nishikawa S; Konno M; Hamabe A; Hasegawa S; Kano Y; Ohta K; Fukusumi T; Sakai D; Kudo T; Haraguchi N; Satoh T; Takiguchi S; Mori M; Doki Y; Ishii H
Int J Oncol; 2013 Apr; 42(4):1437-42. PubMed ID: 23440340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
